{
  "low": {
    "symbol": "JNJ",
    "company_name": "Johnson & Johnson",
    "week_start": "2025-11-19",
    "week_end": "2025-11-26",
    "reasons": [
      "Senaste 5 handelsdagarna: cirka 3.2% prisutveckling.",
      "Uppmätt dagsvolatilitet kring 1.1%, klassad som low risk.",
      "Riskjusterad modellscore (momentum minus volatilitet) ger en relativt attraktiv profil.",
      "Nyhetsanalys (AI-modell, sammanfattning av flera källor):",
      "Nyhetsanalys (AI-modell, FinBERT) baserad på 6 artiklar senaste dagarna.",
      "Sammanfattning för JNJ (Johnson & Johnson): J&J this year lost its patent exclusivity for Stelara, its longtime top-selling drug that treats psoriasis and inflammatory bowel disease. The acquisition brings Halda's candidate HLD-0915, a clinical-stage treatment for prostate cancer, into J&J's oncology portfolio."
    ],
    "score": 0.02682904171882997,
    "risk": "low"
  },
  "medium": {
    "symbol": "CSCO",
    "company_name": "Cisco Systems Inc.",
    "week_start": "2025-11-19",
    "week_end": "2025-11-26",
    "reasons": [
      "Senaste 5 handelsdagarna: cirka 7.9% prisutveckling.",
      "Uppmätt dagsvolatilitet kring 1.7%, klassad som medium risk.",
      "Riskjusterad modellscore (momentum minus volatilitet) ger en relativt attraktiv profil.",
      "Nyhetsanalys (AI-modell, sammanfattning av flera källor):",
      "Nyhetsanalys (AI-modell, FinBERT) baserad på 8 artiklar senaste dagarna.",
      "Sammanfattning för CSCO (Cisco Systems Inc.): Even Cisco’s 2% Dividend Can’t Save Them From Investor Hate Shares of Cisco(NASDAQ:CSCO) are trading just under $78 per share. They’ve done well, up 37% over the past year and still near a 52-week high. Despite this, retail investors on Reddit have turned starkly bearish. Social"
    ],
    "score": 0.07154177912456902,
    "risk": "medium"
  }
}